Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Cerebral deposition of the beta-amyloid peptide (A beta) is an invariant feature of Alzheimer's disease. Since the original isolation and characterization of A beta (ref. 1) and the subsequent cloning of its precursor protein, no direct evidence for the actual production of discrete A beta has been reported. Here we investigate whether A beta is present in human biological fluids using antibodies specific for an epitope within A beta that spans the site of normal constitutive cleavage. These antibodies were used to construct a sandwich-type enzyme-linked immunosorbent assay that detects A beta in cerebrospinal fluid, plasma and conditioned medium of human mixed-brain cells grown in vitro (see also ref. 14). By affinity chromatography, we have purified and sequenced A beta and a novel A beta fragment from human cerebrospinal fluid and conditioned medium of human mixed-brain cell cultures. These findings demonstrate that A beta is produced and released both in vivo and in vitro. These observations offer new opportunities for developing diagnostic tests for Alzheimer's disease and therapeutic strategies aimed at reducing the cerebral deposition of A beta.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies that shed light on the physiological role of Aβ in non-diseased brains show that Aβ plays a role in synaptic transmission and is involved in learning and memory formation [18–22].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [18]
In the citing paper
“Recently, we and others have shown that normal processing of the large amyloid f3 protein precursor ({3-APP) secretes 4-kDa A(3 that is readily detected in human cerebrospinal fluid and in medium conditioned by cultured cells (3)(4)(5)(6).”
From Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain (1995) · cites this paper as [3]
In the citing paper
“The demonstration that A-related peptides with the same N terminals as the CTFs documented here are present in conditioned medium of cultured cells (Seubert et al., 1992;Naslund et al., 1994;Simons et al., 1996;Wang et al., 1996;Xu et al., 1998)”
From Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path (1998) · cites this paper as Seubert et al., 1992
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Self-citationCleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,410
Self-citationMutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,381
Self-citationChartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J., Farlow, M., Ghetti, B., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,127
Tanzi, R. E., McClatchey, A. I., Lamperti, E. D., Villa-Komaroff, L., Gusella, J. F., & Neve, R. L. (1988) · Nature · doi:10.1038/331528a0 · Cited by 1,096
Cited by
Items 1,501–1,600 of 1,726
Koudinova, N. V., Koudinov, A. R., Kezlya, E., Kozirev, K. M., Medvedev, A. E., & Berezov, T. T. (2012) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20125804385 · Cited by 3
Etiology, Genetics, and Pathogenesis of Alzheimer's Disease
McKeon‐O'Malley, C., & Tanzi, R. E. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50024-x · Cited by 4
Alzheimer's disease: stereology in search of specific markers
Vogels, O. J. M. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90038-8 · Cited by 2
EVALUATION OF NOOTROPIC ACTIVITY OF CARICA PAPAYA IN MICE
Kumar, M. N., & Virender, K. (2022) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.7219750 · Cited by 2
Alzheimer’s Disease and Other Neurodegenerative Disorders
Rosén, C., Zetterberg, H., & Blennow, K. (2015) · Springer eBooks · doi:10.1007/978-3-319-01225-4_20 · Cited by 2
Hoyer, S., & Frölich, L. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_12 · Cited by 2
Klingstedt, T. (2013) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 2
Role of Metals in Alzheimer Disease
Roberts, B. R., & Bush, A. I. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch24 · Cited by 2
Proteolytic Processing of the Amyloid Precursor Protein of Alzheimer’s Disease
Lichtenthaler, S. F., Masters, C. L., & Beyreuther, K. T. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57092-6_19 · Cited by 2
Löffler, J., Langui, D., Probst, A., & Huber, G. (1994) · Neurochemistry International · doi:10.1016/0197-0186(94)90086-8 · Cited by 2
Cazorla, P., Aldudo, J., Haas, C., Vázquez, J., Valdivieso, F., & Bullido, M. J. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(94)00083-3 · Cited by 2
The recognition of haemoglobin by antibodies raised for the immunoassay of β‐amyloid
Cutler, P., Brown, F., Camilleri, P., Carpenter, D., George, A. R., Gray, C. W., Haran, M., & Stewart, B. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00696-0 · Cited by 2
Siemers, E., Dean, R. A., Demattos, R. B., Hutton, M. L., Blennow, K., Shaw, L. M. J., & Holtzman, D. M. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1332-9 · Cited by 2
The Principal Inferior Olivary Nucleus in Aging and Alzheimer's Disease
Lasn, H. (2006) · Figshare · Cited by 2
Usefulness of Cerebrospinal Fluid Biomarkers in Diagnosis of Early Alzheimer's Disease
Herukka, S. (2007) · Cited by 2
Channel Formation by a Neurotoxic Beta Amyloid Peptide, Aβ25–35
Lin, M., Mirzabekov, T. A., & Kagan, B. L. (1996) · Springer eBooks · doi:10.1007/978-1-4899-0209-2_39 · Cited by 2
Processing of the amyloid β-protein precursor
Golde, T. E., & Younkin, S. G. (1995) · Elsevier eBooks · doi:10.1016/b978-012286965-5/50009-1 · Cited by 2
Amyloid βA4 of Alzheimer’s Disease: Structural Requirements for Folding and Aggregation
Hilbich, C., Kisters–Woike, B., Masters, C. L., & Beyreuther, K. T. (1994) · Springer eBooks · doi:10.1007/978-3-662-01135-5_3 · Cited by 2
Khan, Q. U. A., & Graff‐Radford, N. R. (2017) · Wiley eBooks · doi:10.1002/9781118661895.ch11 · Cited by 4
In vitro reconstitution demonstrates the amyloid-beta mediated myelin membrane deformationPreprint
Tiwari, A., Pradhan, S., Sannigrahi, A., Jha, S., Chattopadhyay, K., Biswas, M., & Saleem, M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.13.456302 · Cited by 3
“While the non-aggregated forms of Aβ are known to be physiological constituents of cerebrospinal fluid, the neuritic plaques are rich in fibrillar forms of Aβ (Selkoe, 2000; Seubert et al, 1992).”
BackgroundStudies of the Amyloid Precursor Protein (APP) in Brain: Regulation of APP-Ligand Binding
Multhaup, G. (1994) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-01135-5_8 · Cited by 2
Signaling by β-Amyloid Precursor Protein
Furukawa, K. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-475-7_11 · Cited by 2
Genetic Variability and Alzheimer’s Disease
Hardy, J., MULLAN, M. J., Crawford, F., Duff, K., Crook, R., Diaz, P., Bennett, C. R., Houlden, H., Fidani, L., Goate, A., et al. (1994) · Springer eBooks · doi:10.1007/978-3-662-01135-5_18 · Cited by 2
[The scavenger receptor and its importance in amyloid processes].
Aguilar-Gaytán, R., & Mas‐Oliva, J. (2002) · PubMed · Cited by 2
Neurotoxicity of the Alzheimer’s β-Amyloid Peptide
Howlett, D. R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-888-5_6 · Cited by 1
Amorphous Aggregation of Amyloid Beta 1‐40 Peptide in Confined Space
Foschi, G., Albonetti, C., Liscio, F., Milita, S., Greco, P., & Biscarini, F. (2015) · ChemPhysChem · doi:10.1002/cphc.201500602 · Cited by 1
The metabolism of the amyloid precursor protein and its relevance to Alzheimer's disease
Sinha, S. (1995) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02172030 · Cited by 2
Self-citationKoudinov, A. R., Koudinova, N. V., Kezlya, E., Kozirev, K. M., Medvedev, A., & Berezov, T. T. (2012) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750812010076 · Cited by 4
Pathological Validation of Animal Models of Dementia
Pirici, D. N., Broeckhoven, C. V., & Kumar‐Singh, S. (2010) · Neuromethods · doi:10.1007/978-1-60761-898-0_7 · Cited by 2
MOLECULAR GENETICS OF ALZHEIMER DISEASE
Parvathy, S., & Buxbaum, J. D. (2002) · Cited by 2
Comparing In vitro Protein Aggregation Modelling Using Strategies Relevant to Neuropathologies
Nadais, A., Martins, I., Henriques, A. G., Trigo, D., & Silva, O. A. B. D. C. E. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01539-z · Cited by 2
“This fragment is in turn cleaved, resulting in Aβ40 or Aβ42 peptide (several species are possible outcomes) and AICD (Bukhari et al. 2017; da Cruz e Silva et al. 2004; Seubert et al. 1992; Vitoria et al. 2022; Younkin 1998).”
Place cell physiology in a transgenic mouse model of Alzheimer's disease
Yi, M. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Work Intensification & Emotional Labour among University Lecturers
Jaskani, J. H. (2014) · European Journal of Business and Management · Cited by 5
Amyloid Deposition as the Central Event in the Etiology and Pathogenesis of Alzheimer’s Disease
Hardy, J., & Duff, K. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-8149-9_4 · Cited by 1
Aβ(25–35) Attenuated SREBP Level in Nuclear Extracts of Serum-Deprived Human Neuroblastoma Cells
Kelicen, P., Cincioğlu, M., Hızlı, F., & Nordberg, A. K. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9832-4 · Cited by 1
“The processing of APP has become a major focus of research into AD. The principal proteolytic cleavage of APP is performed by a protease designated c-secretase [9, 10 ], and is the last step in the generation of Ab from APP before Ab precipitates in the amyloid plaques in the brain of AD patients [11–15].”
BackgroundLanning, J. D., & Meredith, S. C. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_14 · Cited by 1
Copper and Alzheimer Disease: The Good, the Bad and the Ugly
Hung, Y. H., Bush, A. I., & Cherny, R. A. (2012) · Springer eBooks · doi:10.1007/978-1-4419-9663-3_30 · Cited by 1
The Molecular Mechanism of Amyloidosis in Alzheimer’s Disease
Zagorski, M. G. (1999) · CRC Press eBooks · doi:10.1201/9780203909607.ch14 · Cited by 2
Alzheimer’s Disease and Mechanism-Based Attempts to Enhance Cognition
Draffin, J. E., Knafo, S., & Heneka, M. T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417042-1.00009-7 · Cited by 1
The amyloid beta-precursor protein—The unappreciated cerebral anticoagulant
Schmaier, A. H. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.05.037 · Cited by 1
Andreasen, N., Hesse, C., Davidsson, P., Minthon, L., Wallin, A., Winblad, B. G., Vanderstichele, H., Vanmechelen, E., & Blennow, K. (2017) · Cited by 1
Peptide Vaccine for Alzheimer's Disease
Solomon, B. (2006) · Elsevier eBooks · doi:10.1016/b978-012369442-3/50079-9 · Cited by 1
Amyloid-β As a Biologically Active Peptide in CNS
Gamkrelidze, G. N., Yun, S. H., & Trommer, B. L. (2006) · Springer eBooks · doi:10.1007/0-387-25443-9_30 · Cited by 1
Glabe, C. G., & Bush, A. I. (2007) · Springer eBooks · doi:10.1007/978-0-387-35135-3_7 · Cited by 3
Production of Amyloid β Protein from Normal and Mutated Amyloid β Protein Precursors
Golde, T. E., Cai, X., Cheung, T. T., Shoji, M., & Younkin, S. G. (1994) · Springer eBooks · doi:10.1007/978-3-662-01135-5_4 · Cited by 1
Modulation of APP Processing by Neurotransmission
Nitsch, R. M., Slack, B. E., Farber, S. A., Deng, M., Borghesani, P. R., Wurtman, R. J., & Growdon, J. H. (1995) · Advances in behavioral biology · doi:10.1007/978-1-4757-9145-7_16 · Cited by 1
BACE: A (Almost) Perfect Target for Staving off Alzheimer's Disease
Sinha, S. (2010) · Methods and principles in medicinal chemistry · doi:10.1002/9783527630943.ch14 · Cited by 2
Self-citationMechanism of Cerebral Amyloidosis in Alzheimer’s Disease
Allsop, D., Clements, A., Kennedy, H., Walsh, D. M., & Williams, C. H. (1994) · Springer eBooks · doi:10.1007/978-3-662-01135-5_5 · Cited by 1
Interaction of Alzheimer Amyloid Peptide with Cell Surfaces and Artificial Membranes
Bateman, D. A., & Chakrabartty, A. (2011) · Wiley eBooks · doi:10.1002/9783527634323.ch11 · Cited by 1
Neurotoxicity of amyloid β-protein and the amyloid β-protein precursor
Yoshikawa, K. (1995) · Elsevier eBooks · doi:10.1016/b978-012286965-5/50010-8 · Cited by 1
Alzheimer Disease: Oxidative Stress and Compensatory Responses
Moreira, P. I., Nunomura, A., Zhu, X., Lee, H., Aliev, G., Smith, M. A., & Perry, G. L. (2009) · Contemporary clinical neuroscience · doi:10.1007/978-1-60327-342-8_7 · Cited by 1
“Yet, it has been shown that this peptide is present in the CSF and plasma of healthy individuals throughout life [46, 47].”
BackgroundPurification and Quantification of Neural α-synuclein
Mollenhauer, B., & Schlossmacher, M. G. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00041-5 · Cited by 5
Domain swapping as a molecular mechanism in amyloidosis
Wahlbom, M. (2007) · Lund University Publications (Lund University) · Cited by 1
Future directions for research on Alzheimer's disease
Lieberburg, I. M. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90187-2 · Cited by 1
Self-citationThe Effect of Apolipoprotein E Genotype on Biochemical Markers of Alzheimer's Disease
Schenk, D., Lieberburg, I. M., Motter, R. N., & Seubert, P. A. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb32602.x · Cited by 2
Self-citationIsolation and characterization of soluble β-amyloid and apolipoproteins from cerebrospinal fluid
Kudinova, N. V., Beavis, R. C., Berezov, T. T., & Kudinov, A. R. (1997) · Bulletin of Experimental Biology and Medicine · doi:10.1007/bf02446843 · Cited by 1
Chaperoning Amyloid in Alzheimer’s Disease: The Art of Avoiding Sticky Situations?
Frangione, B., Castaño, E. M., Prelli, F., Soto, C. A., Ghiso, J. A., & Wısnıewskı, T. (1996) · Springer eBooks · doi:10.1007/978-3-642-80109-9_13 · Cited by 1
Characterization of endogenous APP processing in a cell-free system
Brown, A. M., Potempska, A., Tummolo, D. M., Spruyt, M. A., Jacobsen, J. S., & Sonnenberg‐Reines, J. (1998) · AGE · doi:10.1007/s11357-998-0003-y · Cited by 2
KÖNIG, G., GRAHAM, P., Bushnell, A. F., Webster, S. M., Wunderlich, D. A., & Perlmutter, L. S. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34444.x · Cited by 1
Linking Amyloid Precursor Protein Processing and Tau-Related Pathology in Alzheimer’s Disease
Kosik, K. S., Ferreira, A., Knowles, R. B., Leclerc, N. M., & Greenberg, S. M. (1995) · Springer eBooks · doi:10.1007/978-3-642-79423-0_19 · Cited by 1
Molecular Biology and Pathology of Alzheimer’s Disease
Beyreuther, K. T., Multhaup, G., & Masters, C. L. (1993) · Springer eBooks · doi:10.1007/978-3-642-84949-7_2 · Cited by 1
Genetically Engineered Models of Human Age-Related Neurodegenerative Diseases
Vickers, J. C. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50027-5 · Cited by 1
Amyloid (Tace, Bace) and Presenilin Proteases Associated with Alzheimer’s Disease
Marks, N., & Berg, M. J. (2002) · Springer eBooks · doi:10.1007/0-306-46847-6_11 · Cited by 2
Effects of a Peripheral Anti-Aβ Antibody on Plasma and CNS Aβ Clearance
Holtzman, D. M., Bales, K. R., Paul, S. M., & Demattos, R. B. (2003) · Springer eBooks · doi:10.1007/978-3-642-59332-1_8 · Cited by 1
Moskovitz, J., & Bush, A. I. (2005) · Oxidative stress and disease · doi:10.1201/9781420026559.ch11 · Cited by 1
Dietary Zinc in Brain Development, Behavior, and Neuropathology
Levy, M. A., & Bray, T. Μ. (2005) · Nutrition, brain, and behavior./Nutrition, brain and behavior · doi:10.1201/9780203564554.ch16 · Cited by 3
Arbez, N. (2005) · HAL · Cited by 2
New therapeutic patents for Alzheimer’s disease
(1998) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.8.12.1751 · Cited by 1
Wang, J., Hecimovic, S. K., & Goate, A. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200300078 · Cited by 1
Genetic Defects in Early Onset Alzheimer’s Disease and Related Disorders
the Alzheimer’s Disease Research Group, Hendriks, L., & Broeckhoven, C. V. (1994) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-01135-5_19 · Cited by 1
Azouz, M. (2019) · theses.fr (ABES) · doi:10.70675/4c3b6c12z1da5z497cz9e34zea6e6bf189d9 · Cited by 2
Vascular Transport of Alzheimer’s Amyloid β Peptides and Apolipoproteins
Zloković, B. V., Ghiso, J. A., & Frangione, B. (2000) · Springer eBooks · doi:10.1007/978-94-017-1007-7_20 · Cited by 2
Selkoe, D. J. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-8149-9_10
Self-citationPresenilin und β-Amyloid: Schlüsselmoleküle der Alzheimerschen Erkrankung
Haass, C. (1998) · Springer eBooks · doi:10.1007/978-3-7091-6472-3_3
Targeting Early Stages of Alzheimer’s Disease in a Transgenic Model
Lord, A. (2009) · Uppsala University Publications (Uppsala University)
Molecular Genetics and Molecular Biology of Alzheimer’s Disease
Sandbrink, R., & Beyreuther, K. T. (2001) · Springer eBooks · doi:10.1007/978-3-642-59519-6_72
Hock, C., Golombowski, S., Naser, W., Hofmann, M., Hampel, H. J., Kurtz, G., & Müller-Spahn, F. (1996) · Springer eBooks · doi:10.1007/978-3-7091-6889-9_8
Bickel, U. (2000) · Springer eBooks · doi:10.1007/978-94-017-1007-7_2
Transmembrane APP is Distributed into Two Pools and Associated with Polymerized Cytoskeleton
Allinquant, B., Moya, K. L., Bouillot, C., & Prochiantz, A. (1994) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-01135-5_12
The Role of Apolipoprotein E Concentration and Isoform in Amyloid-beta Metabolism In Vivo
Castellano, J. M. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7416v3s
“Aβ, a peptide of unknown physiological function, is naturally secreted (Haass et al., 1992; Seubert et al., 1992; Shoji et al., 1992) following the”
BackgroundSchieb, H. (2011) · DuEPublico (University of Duisburg-Essen)
Chapter 1 Amyloid and Amyloid-Like Protein Aggregates in Neurodegenerative Disease
Golde, T. E. (2007) · Blue books of neurology · doi:10.1016/s1877-184x(09)70052-8
Neurodegeneration and neurogenesis in mouse models of aging and Alzheimer's disease
Bondolfi, L. (2003) · edoc (University of Basel) · doi:10.5451/unibas-003567836
Effec ts of hyperoxia in alzheimers transgenic mice
Cox, A. (2005) · Digital Commons - University of South Florida (University of South Florida)
Approaches to Amyloid Therapies for the Treatment of Alzheimer's Disease
Robichaud, A. J., Kim, J., & Jacobsen, J. S. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc249
Cytotoxic properties of amyloidogenic L68Q cystatin C. A search for therapeutic agents
Ingólfsdóttir, I. E. (2013)
Studies on -secretase activity and products
Frånberg, J. (2010) · Figshare
Therapeutic Potential for Decreasing the Endogenous Toxin Homocysteine: Clinical Trials
Herrmann, W., & Obeid, R. (2009) · Wiley eBooks · doi:10.1002/9783527628100.ch33
Neurobiologic Basis of Age-Related Dementing Disorders
Hof, P. R., Bussière, T., Buxbaum, J. D., & Morrison, J. H. (2006) · Springer eBooks · doi:10.1007/0-387-22621-4_76
Amyloid precursor protein with the Alzheimer´s disease 670/671 mutation : Animal and cellular models
Kloskowska, E. (2008) · Figshare
Jonghe, C. D., & Broeckhoven, C. V. (1999) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(99)80063-7
Poon, H. F. (2005) · UKnowledge (University of Kentucky)
Mechanisms of Brain Region-Specific Amyloid-beta Deposition
Bero, A. W. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7cj8bh2
“Following its intracellular generation, Aβ is secreted into the extracellular fluid of the brain in soluble form (Haass et al., 1992; Seubert et al., 1992; Shoji et al., 1992).”
BackgroundVukic, V. (2008) · uO Research (University of Ottawa) · doi:10.20381/ruor-12230
Role of the 39-kDa receptor-associated protein (RAP) in Alzheimer's disease
Hoang, T. (2012) · UTAS Research Repository · doi:10.25959/23206328 · Cited by 1
Hvoslef‐Eide, M. (2012) · ORCA Online Research @Cardiff (Cardiff University)
Amyloid β-protein, Cystatin C and Cathepsin B as Biomarkers of Alzheimer's Disease
Sundelöf, J. E. (2010) · Uppsala University Publications (Uppsala University)
Öst, M. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Haass, C. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57092-6_20
NMR studies on interactions between the amyloid β peptide and selected molecules
Wahlström, A. (2011) · DiVA (Digitala Vetenskapliga Arkivet)
Metadata
- Authors
- Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberburg, I., & Schenk, D.
- Affiliations
- Austrian Academy of Sciences (AT)
- Venue
- Nature
- Published
- 1992-09
- Volume
- 359
- Issue
- 6393
- Pages
- 325-327
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2086278983
- Cited by
- 1,731
- References
- 28
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 32 · 2023: 19 · 2022: 22 · 2021: 31 · 2020: 28 · 2019: 25 · 2018: 35 · 2017: 39 · 2016: 31 · 2015: 48 · 2014: 46 · 2013: 39 · 2012: 50
- FWCI
- 72.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, cerebrospinal fluid, plasma, conditioned medium, sandwich ELISA, affinity chromatography, epitope-specific antibodies, amyloid deposition, diagnostic biomarkers
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Antibodies, Monoclonal, Brain, Cells, Cultured, Cross Reactions, Enzyme-Linked Immunosorbent Assay, Humans, Molecular Sequence Data, Peptide Fragments, Radioimmunoassay, Solubility, Amyloid beta-Peptides, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.